Indiana AG Settles with J&J, Distributors and Lead Attorney Has Feedback
AG Todd Rokita announces a settlement with Johnson & Johnson and opioid distributors.
Drugs & Medical Devices
Metformin Should be ‘Protocolized’ for Anti-Psychotic Weight Gain
Psychiatrist says Metformin should be given upfront to patients on anti-psychotic medications to manage weight.
Gabapentin Reduces Need for Opioids in Squamous Cell Treatment
Research shows physicians may be able to use gabapentin to help manage head, neck cancer pain and reduce the need for opioids.
Vancouver’s SAFER Program Offers Another Option for Recovery
The Safer Alternatives for Emergency Response program provides medications as substitutes to illegal drug supply.
Study Examines Prevalence of Prescribing Opioids After Skin Surgery
Research shows physicians commonly prescribe addictive painkillers after skin surgeries.
Adding Opioid Use Disorder Training in Med School Could Save Lives
Training students to properly prescribe buprenorphine can help curb the crisis.
Florida Governor Signs Fentanyl, Meth Sentencing Bill into Law
Florida imposes harsh sentencing guidelines for dealers who cause drug fatalities.
West Virginia to Settle with Teva, AbbVie’s Allergan
West Virginia announces settlement with two drug makers.
Experts Say Fentanyl Issue is Only Part of a Larger Crisis
Addiction is on the rise and is half the battle when it comes to fighting the opioid crisis.
MindMed Reports Favorable Results for its Neuro-drugs
Opioid withdrawal drug garners positive results in a clinical trial.